Application of favipiravir in the preparation of drugs for inhibiting the proliferation of canine distemper virus
A canine distemper virus and favipiravir technology, applied in the field of medicine, can solve the problem that no favipiravir has inhibited the measles virus, and achieve the effects of good antiviral efficacy, low toxicity and significant antiviral efficacy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] Embodiment 1: Favipiravir (T-705) canine distemper virus inhibition experiment
[0028] The experimental method is as follows:
[0029] 1. Drug configuration and dilution
[0030] T-705 was dissolved in DMEM medium at a final concentration of 5 mg / ml, and serially diluted to 1250, 625, 312.5, 156.25, 78.125 μg / ml, stored at 4 degrees, and used up within a week.
[0031] 2. Virus Titer Determination
[0032] Vero cells are introduced into the 96-well plate and grown to 80%-90%, and the virus sample is diluted into different dilutions by 10 times with cell maintenance solution (2% FBS in DMEM), starting from 10 -1 to 10 -8 , after aspirating the cell growth solution in the 96-well cell culture plate, inoculate Vero cells with different dilutions of virus, inoculate 100 μl per well, and place at 37°C, 5% CO 2 Cultured in the incubator for 3 days. The cell supernatant was discarded, and 100 μl of cold acetone was added to each well to fix at minus 20 overnight. Discar...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


